Webinar
Potomac Ventures Last Call
Join Alumni Ventures’ Matt Caspari for a final opportunity to explore and invest in Potomac Ventures before the investment window closes.
This session will provide a comprehensive update on the fund’s portfolio, recent investments, and how the team is strategically positioning the fund to capitalize on emerging opportunities. Matt will discuss key startups backed by Potomac Ventures and how the fund is targeting sectors with high-growth potential.
Whether you’re a current investor or considering joining before the deadline, this webinar will offer valuable insights into the fund’s investment strategy and long-term outlook. Don’t miss this chance to connect with the team and get your questions answered before the fund closes.
Why Attend?
- HomePortfolio Insights: Learn about the companies backed by Potomac Ventures and their growth trajectories.
- HomeSector Focus: Discover why Potomac Ventures is targeting specific industries for outsized returns.
- HomeFinal Opportunity: Understand the timeline and reasons to act before the investment window closes.
Reserve your spot today to participate in Potomac Ventures before it’s too late. Alumni Ventures is America’s largest venture capital firm for individual investors.
About your presenter
Overview
Matt Caspari invests in mission-driven founders building the next generation of iconic companies—entrepreneurs tackling the world’s hardest, highest-stakes problems. He backs breakthrough technologies with the potential to redefine critical industries, unlock new markets, and create a more sustainable, secure future.
Before Alumni Ventures, Matt was a two-time venture-backed founder/CEO and a leader of the innovation team at Nike. He founded Aurora Biofuels, a deep-tech venture that grew to 100+ employees and secured more than $100 million in funding before its acquisition by Reliance Industries. Earlier, he advised life science multinationals at Cambridge Pharma Consultancy (acquired by IMS Health) and gained experience on Bloomberg’s M&A team. Matt holds a BS in Biochemistry from Georgetown University and an MBA with a Certificate in Entrepreneurship from UC Berkeley.
Funds actively worked on
Investment Area of Focus
His investment lens favors bold solutions to global challenges and durable advantages rooted in technology and aligned with long-term megatrends. This translates to surgical robots powered by physical AI, next-generation energy systems, space-based infrastructure, longevity therapeutics, and more. The through-line is the potential for extraordinary value creation at the intersection of deep science and global need.
Representative investments Matt has led for Alumni Ventures include Andromeda Surgical and Cytronic (Physical AI); Arda Therapeutics and Cambrian Biopharma (Technologies for the Human Body); Max Space and Orbital Operations (Space Infrastructure); and Fortera and Mainspring Energy (The New Energy Stack). Alumni Ventures’ Deep Tech portfolio also includes companies such as Axiom Space, Ayar Labs, Cohere, Frore Systems, Groq, Hawkeye360, Hayden AI, Lambda, Radiant, and Rigetti (Nasdaq: RGTI).